These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6231416)

  • 1. Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer.
    Nicholson RI; Walker KJ; Turkes A; Turkes AO; Dyas J; Blamey RW; Campbell FC; Robinson MR; Griffiths K
    J Steroid Biochem; 1984 Jan; 20(1):129-35. PubMed ID: 6231416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.
    Nicholson RI; Walker KJ
    Chemioterapia; 1985 Jun; 4(3):249-51. PubMed ID: 3161643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
    Jeppsson S; Rannevik G; Thorell JI; Wide L
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man.
    Besser GM; McNeilly AS; Anderson DC; Marshall JC; Harsoulis P; Hall R; Ormston BJ; Alexander L; Collins WP
    Br Med J; 1972 Jul; 3(5821):267-71. PubMed ID: 4339974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer.
    Walker KJ; Turkes A; Williams MR; Blamey RW; Nicholson RI
    J Endocrinol; 1986 Nov; 111(2):349-53. PubMed ID: 2947964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mammalian luteinizing hormone releasing hormone (LH-RH), and of an analog (ICI 118630), on luteinizing hormone and ovarian steroid (progesterone, oestradiol) secretions in laying hens. (Gallus domesticus).
    Guémené D; Williams JB
    Life Sci; 1986 Aug; 39(6):541-7. PubMed ID: 2942749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM; Thompson IE; Taymor ML
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H; Jung C; Taubert HD
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
    Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer.
    Nicholson RI; Walker KJ; Turkes A; Dyas J; Plowman PN; Williams M; Blamey RW
    J Steroid Biochem; 1985 Nov; 23(5B):843-7. PubMed ID: 2934580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men.
    Faure N; Labrie F; Belanger A; Lemay A; Raynaud JP; Von der Ohe M; Fazekas AT
    J Endocrinol Invest; 1982; 5(6):355-60. PubMed ID: 6820372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
    Williams MR; Walker KJ; Turkes A; Blamey RW; Nicholson RI
    Br J Cancer; 1986 May; 53(5):629-36. PubMed ID: 2941044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men.
    Faure N; Labrie F; Lemay A; Bélanger A; Gourdeau Y; Laroche B; Robert G
    Fertil Steril; 1982 Mar; 37(3):416-24. PubMed ID: 6800852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
    Jeppsson S; Rannevik G; Thorell JI
    Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic cancer: treatment with long-acting LHRH analogue.
    Williams G; Allen JM; O'Shea JP; Mashiter K; Doble A; Bloom SR
    Br J Urol; 1983 Dec; 55(6):743-6. PubMed ID: 6228283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.